News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

New Vaccine in Development at University of Buffalo Could Eradicate Pneumonia and Prevent the Deaths of Nearly One Million Children Under Five Worldwide Each Year

New vaccine has potential to reduce volume of clinical laboratory testing for bacterial and viral infections

By now, nearly all pathologists and clinical laboratory scientists acknowledge that advances in molecular diagnostics and genetic testing are contributing to significant improvements in patient care. Now comes news of a comparable breakthrough in another field of medicine with the potential to protect many individuals from pneumonia and similar infectious diseases.

A new way to develop vaccines made the news recently. Researchers at the University of Buffalo (UB) in New York have found a new way to reduce infections of specific and widespread Streptococcus pneumoniae (pneumococcus) diseases.

This cutting-edge pneumococcal vaccine allows Streptococcus pneumoniae to colonize and live inside the body as long as there is no risk to the host. When a threat is detected, the vaccine establishes an immune system response to annihilate the disease-causing bacteria. (more…)

IBM Watson Health to Acquire Truven Health Analytics and Its Millions of Patient Records for $2.6 Billion

IBM Health’s data combined with Truven’s patient records will create an enormous big-data collection representing 300 million patient lives

If any pathologist or clinical laboratory manager still doubts the importance of healthcare big data, the multi-billion-dollar acquisition of Truven Health Analytics by IBM should put those doubts to rest.

Last month, IBM Corp. (NYSE:IBM) announced an agreement to acquire Truven Health Analytics, (Truven) for $2.6 billion. Truven is a provider of cloud-based healthcare, analytics, and insights and is based in Ann Arbor, Michigan. (more…)

Penn Medicine Informatics Taps Medical Laboratory Data and Three Million Patient Records Over 10 Years to Evaluate Patients’ Sepsis Risk and Head Off Heart Failure

This healthcare big data project’s tools and predictive models involve real-time monitoring of patient data and are expected to be available soon to other to providers

One healthcare big data project has begun to report progress on using predictive analytics to improve patient care in the diagnosis and management of such health conditions as sepsis and heart failure. This pioneering effort is being done at the University of Pennsylvania Health System’s (Penn Medicine’s), Institute for Biomedical Informatics (IBI).

What will be of high interest for pathologists and clinical laboratory executives is how this big data project incorporates lab test results into the effort.

Recently, Penn Medicine announced Penn Signals, a big-data project that, in part, relies on the lab data housed in the academic medical center’s laboratory information system (LIS) as well as its outpatient and inpatient data house in its electronic health record (EHR) system. (more…)

Researchers at University of Rhode Island Unveil Lab-on-Paper Test Capable of Multireagent Diagnostics: Could Enable ‘Diagnostics Without the Lab’ say Developers

New diagnostic capabilities could enable clinical laboratories to obtain multiple outcomes on single fluidic strip tests

Researchers at the University of Rhode Island (URI) have developed a paper-based microfluidic valve technology that some claim may revolutionize existing lateral-flow tests. There is the potential for this innovation to eventually enable pathology groups and medical laboratories to conduct a wide variety of complex medical diagnostics on single fluidic test strips, such as those used to diagnose pregnancy and strep throat, according to a university statement.

Testing Multiple Biomarkers Using a Single Test Strip

Fluidic test strips commonly in use today are generally capable of rendering only one result. However, by combining their new paper-based valve platform with standards strip tests, the URI research team has produced strip tests capable of answering more challenging medical questions.

The evolution of the new technology, dubbed “Lab-on-Paper,” follows the development of the team’s earlier “lab-on-a-chip” device, which the researchers began developing back in 2005. (more…)

New Sepsis Management Standards for New York Hospitals Will Put Greater Emphasis on Use of Clinical Laboratory Tests for Diagnosis and Treatment

There will be more focused lab testing and public reporting of sepsis results as New York State addresses growing problem following death of 12-year-old boy.

New York State will implement tougher standards for the diagnosis and treatment of sepsis in hospitals. One consequence is expected to be more medical laboratory testing for patients suspected of having sepsis.

It may also mean that clinical laboratory test results will get increased scrutiny by physicians who, under the new requirements, must become faster at making an accurate diagnosis of sepsis. These developments were announced by New York Governor Andrew M. Cuomo in his State of the State message on January 9. (more…)

;